Myriad Genetics (MYGN) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $4.56 +1.33%
Revenue Growth %: -2.7%
Financial Fact:
Earnings per basic share: -0.02
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -2.7%
Financial Fact:
Earnings per basic share: -0.02
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q4 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $211 million versus the consensus estimate of $213.31 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns
- Quantum Computing Inc (QUBT) call put ratio 6.5 calls to 1 put with a focus on June 26 weekly 12.50 calls as share price up 3.1%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
